Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;25(4):313-26.
doi: 10.1007/s10637-007-9053-8. Epub 2007 May 5.

A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance

Gene L Bidwell 3rd  1 , Aisha N Davis, Izabela Fokt, Waldemar Priebe, Drazen Raucher
Affiliations

A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance

Gene L Bidwell 3rd et al. Invest New Drugs. 2007 Aug.

Abstract

The ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a major obstacle for successful anticancer therapy. One major mechanism of resistance involves cellular drug efflux by expression of P-glycoprotein (P-gp), a membrane transporter with a wide variety of substrates. Anthracyclines are especially prone to induction of resistance by the P-gp mechanism. P-gp mediated resistance is often confronted by use of P-gp inhibitors, synthesis of novel analogs, or conjugating drugs to macromolecular carriers in order to circumvent the efflux mechanism. In this report, the effect of free and Elastin-like polypeptide (ELP) bound doxorubicin (Dox) on the viability of sensitive (MES-SA and MCF-7) and multidrug resistant (MES-SA/Dx5 and NCI/ADR-RES) human carcinoma cells was studied in vitro. The resistant MES-SA/Dx5 cells demonstrated about 70 times higher resistance to free Dox than the sensitive MES-SA cells, and the NCI/ADR-RES cells were about 30 fold more resistant than the MCF-7 cells. However, the ELP-bound Dox was equally cytotoxic in both sensitive and resistant cell lines. The ELP-bound Dox was shown to accumulate in MES-SA/Dx5 cells, as opposed to free Dox, which was rapidly pumped out by the P-gp transporter. Since ELP is a thermally responsive carrier, the effect of hyperthermia on the cytotoxicity of the ELP-Dox conjugate was investigated. Both cytotoxicity and apoptosis were enhanced by hyperthermia in the Dox resistant cells. The results suggest that ELP-Dox conjugates may provide a means to thermally target solid tumors and to overcome drug resistance in cancer cells.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nat Rev Drug Discov. 2006 Mar;5(3):219-34 - PubMed
    1. J Control Release. 1998 Jul 31;54(2):223-33 - PubMed
    1. Blood. 1996 Jul 15;88(2):633-44 - PubMed
    1. Eur J Pharm Sci. 2003 Sep;20(1):1-16 - PubMed
    1. Cancer Res. 2001 Feb 15;61(4):1548-54 - PubMed

Publication types

MeSH terms

LinkOut - more resources